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Abstract
CRISPR-Cas systems have been used with single-guide RNAs for accurate gene disruption and
conversion in multiple biological systems. Here we report the use of the endonuclease Cas9 to
target genomic sequences in the C. elegans germline, utilizing single-guide RNAs that are
expressed from a U6 small nuclear RNA promoter. Our results demonstrate that targeted, heritable
genetic alterations can be achieved in C. elegans, providing a convenient and effective approach
for generating loss-of-function mutants.
Clustered, regularly interspaced, short palindromic repeats (CRISPR) and CRISPR-
associated (Cas) systems are adaptive mechanisms evolved by bacteria and archaea to repel
invading viruses and plasmids1, 2. CRISPR-Cas systems incorporate foreign DNA sequences
into host CRISPR loci to generate short CRISPR RNAs (crRNAs) that direct sequence-
specific cleavage of homologous target double-stranded DNA by Cas endonucleases3, 4.
Recent work with the S. pyogenes type II CRISPR system, which requires the nuclease
Cas9, a targeting crRNA, and an additional trans-activating crRNA (tracrRNA), has shown
that fusing the crRNA to the tracrRNA to form a single guide RNA (sgRNA) is sufficient to
direct Cas9-mediated target cleavage4. This system has been used for genome engineering in
yeast5, Drosophila6, human and mouse cell lines7–10, and in zebrafish and mouse11, 12. Here
we configured Cas9 and sgRNAs for targeted gene disruption in the nematode C. elegans.
We first generated vectors to express Cas9 and sgRNAs in the germline (Fig. 1a). An SV40
nuclear localization signal (NLS) was added to the 3′  end of the Cas9 open reading frame to
ensure the enzyme would be properly localized to the nucleus8, 10. To drive expression of
transcripts encoding this Cas9-SV40 NLS fusion protein, we utilized the promoter sequence
from the gene eft-3, selected for its effectiveness in driving expression in the germline13.
While previous studies have utilized vectors containing RNA polymerase III (pol III)
promoters to transcribe small RNAs14 or sgRNAs in mammalian systems, no equivalent
vector has been described in C. elegans. Studying conserved upstream and downstream
regulatory sequences flanking a U6 snRNA gene in C. elegans, we derived a putative pol III
promoter for sgRNA expression (Fig. 1a; Supplementary Fig. 1). It has been suggested that
optimal expression from pol III promoters occurs when the first base transcribed is a
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tpurine15, 16. Combining this finding with the known sequence requirements of CRISPR-Cas
guided cleavage, our sgRNA expression system enables the selection of target sequences of
the form G/A(N)19NGG, where the G/A(N)19 represents a 20 nucleotide sequence that will
recognize a homologous stretch of double-stranded DNA in the genome, and the 3′  NGG
sequence represents the essential protospacer-associated motif (PAM)1 (Fig. 1b).
We designed sgRNAs complementary to coding sequences in the unc-119 and dpy-13 genes.
These genes were selected for targeting because loss-of-function alleles have been isolated
at these loci that cause easily identifiable uncoordinated (Unc) or dumpy (Dpy) phenotypes,
respectively17, 18. Studies have indicated that CRISPR-Cas guided double-strand breaks can
be repaired through the process of non-homologous end joining (NHEJ), generating
insertions and deletions (indels) in the vicinity of the cleavage site7–9, 11. We reasoned that
indels disrupting the coding sequences of unc-119 and dpy-13 would mimic previously
identified alleles causing Unc and Dpy phenotypes.
To verify expression of both Cas9-SV40 NLS and sgRNAs, we microinjected the gonads of
wild type adults, generating transgenic progeny that carry each expression vector alone or
both in stable extrachromosomal arrays19. Total RNA was isolated from these transgenic
lines, and reverse transcription-polymerase chain reaction (RT-PCR) assays were performed
to detect transcripts. These assays confirmed that Cas9-SV40 NLS and sgRNAs are
transcribed in transgenic animals (Fig. 1c), indicating that the eft-3 and pol III promoters in
our vectors are active.
We next investigated whether our Cas9/sgRNA expression system could direct targeted
cleavage and disruption of unc-119 and dpy-13 in the germline. We microinjected animals
with vectors expressing Cas9, one of the two sgRNAs, and a vector driving expression of
mCherry in body wall muscles to label transformed F1 progeny. No mCherry-positive F1
animals displayed Unc or Dpy phenotypes. We isolated these mCherry-positive animals and
screened their F2 progeny for Unc or Dpy phenotypes (Fig. 2a). In two replicate experiments
expressing Cas9 and the unc-119-specific sgRNA, we recovered Unc F2 progeny from 1/27
and 1/105 isolated F1 animals (Fig. 2b). In a third experiment targeting the unc-119 locus
using higher concentrations of our expression vectors (see Supplementary Methods), Unc F2
progeny were recovered from 1/60 F1 animals. When targeting the dpy-13 locus, we
recovered Dpy F2 progeny from 1/210 individual F1 animals (Fig. 2b). In all four
experiments, when Unc and Dpy F2 progeny were identified, they were recovered at a
frequency of 25% from singled F1 animals. All of the F3 progeny from Unc and Dpy F2
mutant animals displayed Unc and Dpy phenotypes, respectively (Fig. 2c and
Supplementary Movies 1–3). These observed patterns of inheritance are consistent with
recessive loss-of-function mutations originating in the germline of injected animals. We
were unable to recover mutant animals from progeny of F1 animals not expressing our
mCherry marker, or from animals injected with Cas9 or sgRNA alone (Supplementary Table
1), suggesting that both components are required for cleavage. To verify that disruptions
targeted unc-119 and dpy-13, we isolated DNA from mutant animals and sequenced regions
spanning the predicted sites of cleavage. The genomes of all Unc mutants and the Dpy
mutant possessed a unique indel located within the expected target sequences, occurring
three to four bases upstream of the PAM sequence (Fig. 2d). All of the identified indels are
predicted to alter the coding sequence of each gene, and would lead to the production of
truncated proteins. These molecular changes are consistent with the phenotypes we observe,
resembling previously characterized loss-of-function mutants. These results indicate that our
vector system enables the expression of Cas9 and sgRNAs in the germline to achieve
targeted, heritable gene disruptions.
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disruptions that do not lead to visible phenotypes, we selected two additional loci (klp-12
and Y61A9LA.1) with no known loss-of-function phenotypes and generated sgRNAs to
target them. We microinjected these animals with Cas9, sgRNA, and mCherry expression
vectors as above, and isolated mCherry-positive F1 progeny. We allowed these F1 animals to
lay eggs and then genotyped these animals by sequencing regions of genomic DNA
spanning expected cleavage sites. In two replicate experiments targeting klp-12 and one
targeting Y61A9LA.1, we generated disruptions in 80.3%, 77. 1%, and 18.1% of the F1s
screened, respectively (Fig. 3a, 3b). Interestingly, at the klp-12 locus, 27 out of 80 F1
animals carrying a disruption were homozygous for a single disruption while other animals
carried two unique disruption alleles. We speculate that these doubly-targeted mutant F1s are
generated through two sequential break and repair events. The first event may occur in the
haploid oocyte, where NHEJ-mediated repair introduces an indel The second event likely
occurs later in the sperm-contributed chromosome, where either NHEJ introduces a second,
unique indel, or through homologous recombination uses the already-disrupted chromosome
as a template and copies the error, yielding a homozygous mutant. We followed the
inheritance of four klp-12 alleles identified in F1 animals by genotyping single mCherry-
negative F2 animals and confirmed the heritability of all of these disruptions (Supplementary
Fig. 3).
To demonstrate an additional screening strategy capable of identifying disruptions that do
not cause obvious phenotypes, we designed our klp-12 sgRNA targeting sequence to overlap
with that of a restriction enzyme, MfeI. When CRISPR-Cas mediated cleavage occurs at this
site, any indels spanning the restriction enzyme recognition sequence would lead to a
restriction fragment length polymorphism in PCR amplicons generated from mutant
genomic DNA (Figure 3C). Using this approach, we were able to distinguish between wild
type animals, singly-disrupted animals, and doubly-disrupted animals (Figure 3C) that were
confirmed by our sequencing analysis described above. These results indicate that when
possible, this method can provide a convenient way to pre-screen a large number of
candidate F1 progeny for sequence disruptions and reduce the number of animals requiring
validation by sequencing.
To assess the possibility of CRISPR-Cas cleavage at off-target loci in our mutant strains, we
searched for other sites in the genome that could potentially be targeted by our sgRNAs.
Evidence suggests that the 12 nucleotides in the target sequence proximal to the PAM are
the most critical determinants of cleavage specificity and may constitute a ‘seed’ region20.
We scanned the genome for sequences of the form (N)12NGG, and selected candidate off-
target sites for each sgRNA that contained the minimum number of mismatches within these
sequences. We sequenced the genomic regions spanning these potential cleavage sites in
several of our mutant strains and found no evidence of cleavage or indels at these loci
(Supplementary Fig. 2). However, these results do not systematically assess the specificity
of CRISPR-Cas guided cleavage in C. elegans and future work will be required to further
investigate the potential for off-target cleavage.
The discovery that RNA-guided endonucleases can cleave target sequences in the nuclei of
eukaryotic cells has enabled genome editing in cultured cells, yeast, vertebrates, and
Drosophila. Here, through the use of a U6 snRNA pol III promoter to drive sgRNA
expression, we demonstrate that CRISPR-Cas guided cleavage can introduce heritable
mutations in C. elegans. In principle, the methodology described here could be applied to
other model organisms in which efficient delivery of DNA to the germline is feasible. Our
results suggest that CRISPR-Cas based systems possess great potential for heritable genome
editing in a wide variety of multicellular eukaryotes.
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Strains and maintenance
The Bristol N2 strain (kindly provided by the Caenorhabditis Genetics Center, University of
Minnesota) was used in all experiments described. All animals were grown on NGM agar
plates seeded with the E. coli bacterial strain OP50, and maintained using standard
procedures21.
Identification of a conserved U6 snRNA pol III promoter
In order to develop a pol III promoter expression vector, we identified a conserved U6
snRNA locus by performing BLAT searches using the consensus U6 snRNA sequence22.
One locus on Chromosome IV was selected for further analysis, and alignment and
conservation tracks were extracted from the UCSC genome browser23. We identified
approximately 80 base pairs of upstream sequence and 10 base pairs of downstream
sequence conserved among several nematode species (see Supplementary Figure 1 for
alignment). We therefore conservatively chose to include 500 bases of upstream sequence
and 237 bases of downstream sequence flanking the snRNA sequence.
sgRNA targeting sequence identification and selection
Using the known sequence requirements of CRISPR-Cas guided cleavage, we searched for
target sequences in the C. elegans genome on the basis of the following criteria:
1. Sequences had to be of the form G/A(N)19NGG, where the G/A(N)19 represents a
20 nucleotide sequence that will recognize a homologous stretch of double-
stranded DNA in the genome, and the 3′  NGG sequence represents the essential
protospacer-associated motif (PAM).
2. If a protein-coding gene knockout is desired, sequences contained within known
open reading frames should be targeted. Although this is not a strict requirement, it
likely ensures that a disruption will create an allele that shifts the canonical reading
frame, often producing premature termination codons.
3. Where possible, it is also desirable to look for target sequences that possess a
restriction enzyme recognition sequence a few bases upstream of the PAM. This
will facilitate pre-screening F1 progeny by restriction digests.
To actually select these sgRNA target sequences, we copied the genomic sequence spanning
all of the coding exons and intervening intronic sequences of a gene of interest from
Wormbase into Microsoft Word and, using the asterisk character as a wildcard, searched for
strings that met the above criteria.
Plasmid construction
To create the Cas9-SV40 NLS expression vector, a worm codon-optimized Cas9 open
reading frame with an internal intron sequence and a 3′  end fused SV40 nuclear localization
signal sequence (see Supplementary Table 2 for a full sequence) was synthetically produced
(Genscript Inc.) and inserted into the vector pUC57. This intron containing open reading
frame was PCR-amplified using the oligonucleotide primers cas9 start F/cas9 tbb-2 UTR R
(see Supplementary Table 2 for a full list of primers used in this study). The promoter region
from the eft-3 gene and 3′  UTR from the gene tbb-2 were PCR-amplified from plasmid
pCFJ601 (obtained from Addgene through the kind gift of E. Jorgensen and C. Frokjaer-
Jensen) using the primers pUC57 EcoRI Peft-3 F/Peft-3 cas9 start R and tbb-2 UTR F/tbb-2
UTR pUC57 R, respectively. These three PCR products (promoter, Cas9-SV40 NLS +
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the Gibson assembly method as previously described24.
To create the pol III promoter expression vector, we ordered two overlapping gBlocks gene
fragments (IDT) collectively containing the 500 upstream nucleotides flanking a conserved
U6 snRNA locus, a target sequence with homology to a portion of the coding sequence of
the unc-119 gene, remaining sequence corresponding to the sgRNA, and 237 nucleotides
downstream of the U6 snRNA locus (see Supplementary Table 2 for full sequences). The
two gBlocks were stitched together by PCR using the primers U6prom EcoRI F/U6prom
HindIII R. This PCR product was then digested with EcoRI and HindIII and ligated into an
EcoRI/HindIII digested pUC57 plasmid, creating vector pU6::unc-119 sgRNA.
To generate the dpy-13 sgRNA expression vector, we used the pU6::unc-119 sgRNA vector
above as a template and amplified two overlapping PCR fragments using the primers
U6prom EcoRI F/dpy-13 gRNA R and dpy-13 gRNA F/U6prom HindIII R. These PCR
products were gel purified, and then mixed together in a second PCR reaction with primers
U6prom EcoRI F/U6prom HindIII R. This final PCR product was digested with EcoRI and
HindIII and ligated into an EcoRI/HindIII digested pUC57 plasmid, creating the vector
pU6::dpy-13 sgRNA.
To generate the klp-12 sgRNA expression vector, we used the pU6::unc-119 sgRNA vector
above as a template and amplified two overlapping PCR fragments using the primers
U6prom EcoRI F/klp-12 gRNA R and klp-12 gRNA F/U6prom HindIII R. These PCR
products were gel purified, and then mixed together in a second PCR reaction with primers
U6prom EcoRI F/U6prom HindIII R. This final PCR product was digested with EcoRI and
HindIII and ligated into an EcoRI/HindIII digested pUC57 plasmid, creating the vector
pU6::klp-12 sgRNA.
To generate the Y61A9LA.1 sgRNA expression vector, we used the pU6::unc-119 sgRNA
vector above as a template and amplified two overlapping PCR fragments using the primers
U6prom EcoRI F/Y61A9LA.1 gRNA R and Y61A9LA.1 gRNA F/U6prom HindIII R.
These PCR products were gel purified, and then mixed together in a second PCR reaction
with primers U6prom EcoRI F/U6prom HindIII R. This final PCR product was digested
with EcoRI and HindIII and ligated into an EcoRI/HindIII digested pUC57 plasmid, creating
the vector pU6::Y61A9LA.1 sgRNA.
DNA microinjection
Plasmid DNA was microinjected into the germline of adult hermaphrodite animals using
standard methods as described previously25. Injection solutions were prepared to contain a
final concentration of 100ng/uL for two replicate unc-119 experiments and the dpy-13
experiment, and 500ng/uL for a third unc-119 experiment and all klp-12 and Y61A9LA.1
experiments. In all injections, we used the vector pCFJ104 (Pmyo-3::mCherry) as a co-
injection marker. The vectors used in this study were present at the following final
concentrations in injection mixes:
(Peft-3::Cas9-SV40 NLS::tbb-2 3′ UTR) : 50 ng/uL
(pU6::unc-119 or dpy-13 sgRNA) : 45 ng/uL
pCFJ104: 5 ng/uL
and
(Peft-3::Cas9-SV40 NLS::tbb-2 3′ UTR) : 250 ng/uL
(pU6::unc-119 or klp-12 or Y61A9LA.1 sgRNA) : 225 ng/uL
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When vectors were injected separately for Figure 1C, the final concentration of DNA was
adjusted to 100 ng/uL by adding DNA ladder.
We have noticed that injections with a total DNA concentration of 500 ng/uL can lead to
sterility (up to 25%) of F1 adult progeny. At present it is difficult to conclude if the cause of
this sterility is due to an overall increase in plasmid DNA delivered in injections, or due to
an increased concentration of a particular plasmid in our injection mix. This increase in
sterility did not significantly affect our ability to recover fertile animals carrying disruptions
at the unc-119, klp-12 and Y61A9LA.1 loci. If sterility does become an issue, we suggest
testing several concentrations of each plasmid when trying to generate targeted disruptions
in genes of interest.
RNA isolation and RT-PCR assays
Total RNA was isolated from lines stably carrying plasmids as extrachomosomal arrays
using Tri reagent (Sigma) as recommended by the manufacturer. RT-PCR assays were
performed using the OneStep RT-PCR kit (Qiagen) according to the protocol described by
the manufacturer. Thirty nanograms of total RNA was used as input for each reaction. The
sequences of primers used are provided in Supplementary Table 2.
Screening for disruptions in animals with no obvious phenotypes and genotyping
To screen for disruptions in the klp-12 gene, we placed F1 animals in 5 uL of single worm
lysis buffer (10 mM Tris pH 8.0, 50 mM KCl, 2.5 mM MgCl2, 0.45% NP-40, 0.45%
Tween-20, 100 ug/mL proteinase K) and lysed the animals for one hour at 60°C, followed
by incubation at 95°C to inactivate the proteinase K. We then amplified a region of genomic
DNA spanning the predicted disruption site by PCR using Phusion High fidelity polymerase
(Thermo Scientific) as recommended by the manufacturer, using all 5 uL of worm lysate as
a template (see Supplementary Table 2 for a list of all primers used for PCR amplification
and genotyping). PCR amplicons were then cleaned using the Genejet PCR purification kit
(Thermo Scientific) as recommended by the manufacturer. 5 uL of PCR product were then
digested with the restriction enzyme MfeI (NEB) per manufacturer recommendations, and
digestion products were resolved on a 1% agarose gel, stained with 100 ug/mL ethidium
bromide, and detected using a UV transilluminator.
To genotype all other animals and loci of interest, single animals were lysed, relevant
regions were amplified by PCR, and PCR products were cleaned as described above.
Cleaned PCR products were then sequenced by Sanger Sequencing methods (Genewiz).
To monitor inheritance of targeted disruptions at the klp-12 locus, we followed the F2
progeny of three F1 animals carrying four alleles with disrupted sequences (two animals
carrying a homozygous mutation and one animal carrying two independent disruptions). We
sequenced single F2 progeny from these animals (Five F2s from each of the homozygous
mutants and 18 F2s from the animal carrying two independent disruptions). We
demonstrated that for all four alleles, the allele found in the F1 generation was passed on
faithfully to the F2 generation. In the case of the F1 carrying two independent disruptions,
we were able to isolate homozygous F2 mutant animals carrying each independent mutant
allele at the expected Mendelian frequencies of 25%.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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A set of vectors that drive expression of Cas9 and sgRNAs in C. elegans. (A) The C. elegans
eft-3 promoter drives transcription of Cas9 with a 3′  SV40 nuclear localization sequence. A
pol III promoter (derived from a U6 snRNA locus) drives transcription of the sgRNA, which
contains a target sequence and a scaffold sequence. (B) A schematic illustration of Cas9
interacting with sgRNA and its genomic target. (C) RT-PCR results demonstrating
expression of Cas9 and sgRNA transcripts. Total RNA was tested from strains carrying
Cas9 vector alone (lanes 1 and 2), unc-119 sgRNA vector alone (lanes 3 and 4), and both
vectors (lanes 5 and 6) with primers specific for Cas9 (top panel) or unc-119 sgRNA
(bottom panel). For all samples, control reactions were run in the absence of Reverse
Transcriptase (-RT; lanes 1, 3, and 5).
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Heritable, targeted gene disruptions in the germline using CRISPR-Cas systems. (A) Wild
type (Bristol N2) adults were injected with vectors expressing Cas9, sgRNA, and a body
wall muscle-specific mCherry marker. mCherry-positive F1 animals were isolated, a small
fraction of which were heterozygous for the disruption. Next, the F2 animals were screened
for mutant phenotypes, reflecting homozygous disruption. All further progeny of these F2
mutants were homozygous for the disruption. (B) A table summarizing the results of the four
experiments, in which 4 disruptions were found out of 402 mCherry-positive F1 animals. (C)
Images of worms from our wild type background line, a disrupted unc-119 line, and a
disrupted dpy-13 line. (D) Sequences of the indel mutations found in our mutant lines.
Insertions are marked in blue, deletions are marked by dashes, and the PAM is marked in
purple. *The third experiment targeting the unc-119 locus utilized five-fold higher
concentrations of expression vectors (see Supplementary Methods for details).
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Heritable, targeted gene disruptions in genes that lead to no obvious phenotypes. (A) A table
summarizing the results of the three experiments, in which 93 disruptions were found out of
173 mCherry-positive F1 animals. (B) Sequences of the indel mutations found in several of
our mutant lines. Insertions are marked in blue, deletions are marked by dashes, and the
PAM is marked in purple. (C) Sequence at the klp-12 locus showing the target PAM site in
purple and the MfeI restriction site in green. (D) An image of a 1% agarose gel showing a
restriction digest of PCR amplicons spanning the klp-12 cleavage site from seven F1
animals. Wild type sequences in lanes 1 and 2 are cut into bands of 280bp and 107bp, while
doubly disrupted sequences remain full length at 387bp in lanes 6 and 7. Lanes 3, 4, and 5
show all three bands, indicating worms that are singly disrupted.
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